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Mutation of TBCK causes a rare recessive
developmental disorder
ABSTRACT
Objective: To characterize the underlying genetic defect in a family with 3 siblings affected by
a severe, yet viable, congenital disorder.
Methods: Extensive genetic and metabolic investigations were performed, and the affected chil-
dren were imaged at different ages. Whole-genome genotyping and whole-exome sequencing
were undertaken. A single large region (.8 Mb) of homozygosity in chromosome 4
(chr4:100,268,553–108,609,628) was identified that was shared only in affected siblings.
Inspection of genetic variability within this region led to the identification of a novel mutation.
Sanger sequencing confirmed segregation of the mutation with disease.
Results: All affected siblings share homozygosity for a novel 4-bp deletion in the gene TBCK
(NM_033115:c.614_617del:p.205_206del).
Conclusions: This finding provides the genetic cause of a severe inherited disease in a family and
extends the number of mutations and phenotypes associated with this recently identified disease
gene. Neurol Genet 2016;2:e76; doi: 10.1212/NXG.0000000000000076
GLOSSARY
WES 5 whole-exome sequencing.
Improvements in next-generation sequencing have revolutionized gene identification in rare dis-
eases, with whole-exome sequencing (WES) now providing a method to identify causal Mende-
lian disease genes in individual families.1
FAMILY REPORT Three siblings born to Caucasian parents with a dysmorphic condition of unknown cause
have been previously reported.2 The affected siblings (2 boys and one girl) presented with profound hypotonia,
global developmental delay, and slow motor development with no progress beyond the ability to sit indepen-
dently. They also had epilepsy and similar distinctive facial features, and the 2 youngest siblings had signs of
precocious puberty. The older sibling died at 9 years of age, and the youngest died at 12 years. The results of
extensive genetic and metabolic screening were normal and MR imaging did not reveal any specific features.
Another male sibling is unaffected.
CASE DESCRIPTIONS The clinical and dysmorphic features of the 3 affected siblings (figure 1) have been
described in detail previously2; in addition, there is one unaffected male sibling.
All affected siblings had epilepsy with onset between 9 months and 3 years, profound hypotonia, strabis-
mus, and global delay. They shared many dysmorphic features including brachy/plagiocephaly, prominent eyes
and shallow orbits, deep transverse palmar creases, and overlapping toes. The second affected sibling had pre-
auricular tags, and the third had inverted nipples. Signs of precocious puberty developed in patient 2 at 7 years
of age and in patient 3 at 5 years of age.
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Clinical events since the original report are sum-
marized for patients 2 and 3.
Patient 2. At the age of 16, he communicates with vo-
calizations and seems to have some level of compre-
hension. He has reduced visual awareness with an
intermittent squint and nystagmus. Epilepsy evolved
from myoclonic jerks around the age of 6 months,
with focal and generalized tonic/clonic seizures from
the age of 3 years, mostly during intercurrent illness.
More recently, these seizures have been well con-
trolled with a combination of lamotrigine and levitir-
acetam. At age 16, he had normal tone and deep
tendon reflexes. He has developed mild elbow, wrist,
knee, and ankle contractures over time and has had 2
hip operations to correct hip dislocation.
Patient 3. In later childhood, her seizures improved
and were reasonably well controlled with lamotrigine
monotherapy. She also received goserelin for preco-
cious puberty. Around the age of 11 years, she had
several admissions to pediatric intensive care for chest
infections. She started to become more sleepy with
lowered core temperature of approximately 35°C
and later became oxygen dependent. She was admit-
ted in her 12th year with a severe chest infection and
died of a sudden cardiac arrest.
INVESTIGATIONS Extensive metabolic investigations
were performed, including CSF amino acids and neu-
rotransmitters, muscle biopsy with histology and
respiratory chain enzymes, white cell enzymes, very
long chain fatty acids, and transferrin isoelectric
focusing, all of which were normal.
All 3 children were imaged at different ages.
Patient 1 had an MR scan at a young age, which
showed abnormal frontal and parietal lobes with
Figure 1 Pedigree of the family studied, photographs, and identification of a homozygous mutation in TBCK
(A) Pedigree showing complete segregation of the TBCK c.614_617del; p.205_206del mutation in the family members available for analysis. (B) Photographs
of the affected siblings. (C) Sanger sequencing traces for all family members available for analysis (2 affected siblings, the parents, and 1 unaffected sibling).
The 3 upper chromatograms represent a reference sequence and the unaffected family members where the heterozygous deletion can be observed. The 2
lower chromatograms represent 2 of the affected siblings where the same deletion can be observed in homozygosity.
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mildly dilated ventricles and absence of the cavum
pellucidum. A skull radiograph showed fusion of
the right lambdoid suture. Patient 2 had an MR
scan at the age of 3 months, which was normal.
Patient 3 had an MR scan at the age of 1½, years
that showed some signal change in the peritrigonal
areas, possibly representing delayed myelination or
dysmyelination. There was also mild cerebellar atro-
phy with a large cisterna magna. Spectroscopy
showed normal peaks for N-acetylaspartate, crea-
tine, and choline.
Genetic investigations included routine karyotyp-
ing, 250k single-nucleotide polymorphism arrays (Af-
fymetrix, Santa Clara, CA), subtelomeric fluorescent
in situ hybridization, and mitochondrial gene analysis.
Despite these investigations, the molecular defect
underlying this disorder had remained unidentified.2
We performed whole-genome genotyping and WES
across 3 children (2 affected and 1 unaffected).
Because both parents are healthy and 3 of 4 children,
of both sexes, were affected, we assumed a recessive
mode of inheritance. Whole-genome genotyping
identified a single large region (.8 Mb) of homozy-
gosity in chromosome 4 (chr4:100,268,553–108,609,
628) that was shared by both affected siblings but was
absent from the unaffected (tables e-1 and e-2, figure
e-1 at Neurology.org/ng). Inspection of the whole-
exome data for genetic variability within this region
led to the identification of a novel 4-bp deletion in
the gene TBCK (NM_033115:c.614_617del:p.205_
206del). Sanger sequencing confirmed segregation of
the mutation with disease (figure 1). The only tissue
available was a lymphocyte cell line from II-3.
However, quantitative PCR analysis revealed no sig-
nificant differences in transcript levels. This work
was approved by UCL Research Ethics Committee
(0071/001).
Standard protocol approvals, registrations, and patient
consents. Ethical review board has approved the use of
human participants for this study. Consent forms
were received from the family participating in the
study.
DISCUSSION A splicing mutation in TBCK, discov-
ered during a large-scale WES project in consanguineous
families, has been recently reported.3 The clinical
symptoms in the patient described previously and the
patients described here are remarkably similar and
include global developmental delay, epilepsy,
dysmorphism, and hypotonia. However, the first
patient also displayed ventricular septal defects and did
not have precocious puberty. The family described here
is not known to be consanguineous.
TBCK is a poorly characterized protein and cur-
rently has no assigned function, although it is re-
ported to be a putative Rab GTPase activating
protein. Recent work has suggested that TBCK may
have a role in epidermal growth factor signaling,4
endocytosis,5 and cell migration.6 Others have shown
that TBCK knockdown suppresses mechanistic target
of rapamycin (mTOR) signaling and inhibits cell pro-
liferation.7 Conversely, others have reported that
TBCK activity inhibits cell proliferation.8 The pau-
city of articles directly investigating TBCK function,
and the conflicting evidence put forward by those that
have, reveals the need for further work to define the
function of TBCK in the context of specific cell types,
and the potentially different roles for alternative iso-
forms. The deletion mutation reported here falls
within exon 11 and creates a premature stop codon.
Clearly, more extensive functional assays are needed
to understand the role of TBCK and the downstream
effects of the mutations so far identified.
The data presented herein and previously3
strongly argue for the role of TBCK in this novel
syndrome.
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